Aging and Drug Therapy: Impact on Pharmacokinetics and Pharmacodynamics in Older Adults

QUESTION

Describe how aging affects pharmacokinetics & pharmacodynamics of the older adult and relate this knowledge to drug therapy and drug dosing for three chronic diseases in a formal Word document that adheres to the seventh edition of the Publication Manual of the American Psychological Association.

Instructions:

Create a patient situation for a 73-year-old man with diagnoses of Cerebrovascular Disease (CVD), Mellitus (DM) Type 2, and Peripheral Artery Disease (PAD) in a two-page scenario that includes objective diagnostic measurements. Include five (5) drugs that may have an adverse impact on the client’s cognition, mobility, continence, and/or balance that are designed to treat the three chronic diseases. Include the three areas listed below in the written assignment:

1. Physiologic changes that may affect drug absorption and excretion and how these changes may manifest themselves clinically in relation to the prescribed drugs.
2. Five (5) questions that you should ask about the client’s drug regimen to determine if the medications are appropriate for the client.
3. Nursing actions aimed at preventing or minimizing potential drug reactions or interactions for each prescribed medication.

ANSWER

Aging and Drug Therapy: Impact on Pharmacokinetics and Pharmacodynamics in Older Adults

Introduction

Aging significantly influences the pharmacokinetics and pharmacodynamics of drugs in older adults. Physiological changes that occur with age can affect drug absorption, distribution, metabolism, and elimination, leading to altered drug responses and potential adverse effects. Understanding these changes is crucial for optimizing drug therapy and dosing in older patients with chronic diseases. This paper presents a patient scenario of a 73-year-old man with diagnoses of Cerebrovascular Disease (CVD), Mellitus (DM) Type 2, and Peripheral Artery Disease (PAD). It explores the physiologic changes that may impact drug absorption and excretion, raises essential questions to assess the appropriateness of the drug regimen, and discusses nursing actions to prevent or minimize potential drug reactions or interactions.

Patient Scenario

Mr. Smith is a 73-year-old man with a medical history of Cerebrovascular Disease (CVD), Mellitus (DM) Type 2, and Peripheral Artery Disease (PAD). He presents with symptoms of intermittent claudication, memory difficulties, and uncontrolled blood glucose levels. Objective diagnostic measurements reveal an ankle-brachial index (ABI) of 0.7, fasting blood glucose of 180 mg/dL, and Mini-Mental State Examination (MMSE) score of 23.

Prescribed Medications

1. Aspirin 81 mg daily for CVD
2. Metformin 1000 mg twice daily for DM Type 2
3. Clopidogrel 75 mg daily for PAD
4. Warfarin 5 mg daily for CVD
5. Ramipril 5 mg daily for CVD and PAD

Physiological Changes and Clinical Manifestations

Absorption and Excretion

Gastrointestinal motility and absorption efficiency may decline with age, affecting drug bioavailability. Delayed drug absorption may lead to delayed therapeutic effects, as seen with metformin, impacting glycemic control in older adults. Additionally, reduced renal function can decrease drug clearance, leading to drug accumulation and increased risk of adverse effects, particularly for drugs excreted primarily by the kidneys, such as metformin and ramipril.

Distribution

Age-related changes in body composition, such as decreased muscle mass and increased body fat, can alter drug distribution. Lipophilic drugs may have an extended half-life in older adults, potentially leading to drug accumulation, as seen with clopidogrel and warfarin. These changes can increase the risk of bleeding or other adverse effects.

5 Questions to Assess Medication Appropriateness

Are there alternative medications with less potential for cognitive impairment or drug interactions that can achieve similar treatment outcomes?
Is the dosage of each medication appropriate considering the patient’s age, renal function, and comorbidities?
Does the patient experience any adverse effects or drug interactions related to the prescribed medications?
Are there any medications that could be potentially deprescribing or reducing doses to minimize polypharmacy and improve overall medication management?
Are there any medications or drug classes that should be avoided due to potential safety concerns in older adults?

Nursing Actions to Prevent or Minimize Drug Reactions

Regularly assess the patient’s cognitive function and functional status to detect any changes that may indicate adverse drug effects.
Monitor renal function and adjust drug dosages accordingly to prevent drug accumulation and toxicity.
Educate the patient and caregivers about potential side effects, drug interactions, and the importance of medication adherence.
Promote a multidisciplinary approach to medication management, involving pharmacists and physicians to ensure appropriateness and safety of the drug regimen.
Regularly review the patient’s drug regimen and consider deprescribing when appropriate, especially for medications with limited benefits or increased risks in older adults.

Conclusion

Aging significantly impacts pharmacokinetics and pharmacodynamics in older adults, influencing drug absorption, distribution, metabolism, and excretion. In the case of the 73-year-old man with CVD, DM Type 2, and PAD, understanding these physiological changes is crucial for optimizing drug therapy and dosing. By assessing medication appropriateness, monitoring for adverse effects, and implementing nursing actions to prevent or minimize drug reactions, healthcare professionals can enhance the safety and efficacy of drug therapy in older patients with chronic diseases.